German biotech firm BioNTech on Monday said that second-quarter revenues more than doubled to 261 million euros ($302 million ...

BioNTech (BNTX) stock gains as the company surpasses Q2 2025 forecasts with 103% YoY revenue growth, thanks mainly to Pfizer ...

Summer heat, outdoor fun … and cold and flu symptoms? The three may not go together in many people’s minds: partly owing to ...

BioNTech stock was rising after the drugmaker reported better-than-expected results early Monday. The company’s ...

Vaccines help protect students, staff, family and the community from serious vaccine-preventable diseases,” a local public ...

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific antib ...

Subtle differences in molecular structure can have a major impact on the performance of mRNA-based drugs. The findings open ...

Should you get vaccinated? Will your insurer pay for it? And will you still be able to find a vaccine? KFF Health News tries to sort out where things stand.

As the country continues to deal with the fallout of the infamous Jeffery Epstein files, The Root is taking a closer look at some of the most polarizing conspiracy theories in American history.

This article explains how aluminum adjuvants work in vaccines, their proven safety record, and addresses common myths and ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

Along with gaining a reputation as a trusted destination, Joyleaf was named Best New Business 2024 by the Roselle Chamber of ...